The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly

Purpose: To define the prevalence of PTEN mutations in a clinical cohort of pediatric subjects with autism spectrum disorders (ASDs), developmental delay/mental retardation (DD/MR), and/or macrocephaly and to assess genotype–phenotype correlations.Methods: Medical records of patients who had clinical PTEN gene sequencing ordered through our institution between January 1, 2005 and December 31, 2007 were abstracted to confirm genetic test results and medical diagnoses. Phenotypic information related to the diagnoses, prenatal history, early developmental milestones, physical characteristics, and family history for those with a confirmed PTEN mutation was also recorded.Results: One hundred fourteen patients were tested during this time period for indications of ASDs (N = 60), DD/MR (N = 49), or macrocephaly only (N = 5). Eleven mutations were identified: five in patients with ASDs and six in those with DD/MR, resulting in a prevalence of 8.3% and 12.2% in these respective clinical populations. All individuals with a PTEN mutation had significant macrocephaly (>2.0 SD)Conclusions: These data illustrate that PTEN gene sequencing has a high diagnostic yield when performed in a selected population of individuals with ASDs or DD/MR and macrocephaly. Germline mutations in PTEN are an important, identifiable etiology among these patients.

[1]  P. Lichter,et al.  Independent Molecular Development of Metachronous Glioblastomas with Extended Intervening Recurrence‐free Interval , 2003, Brain pathology.

[2]  C Eng,et al.  PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. , 1999, Human molecular genetics.

[3]  Christopher Gillberg,et al.  Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[4]  C. Eng,et al.  De novo germline PTEN mutation in a man with Lhermitte-Duclos disease which arose on the paternal chromosome and was transmitted to his child with polydactyly and Wormian bones , 2003, Journal of medical genetics.

[5]  Eric Butter,et al.  Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly , 2007, American journal of medical genetics. Part A.

[6]  I. Temple,et al.  Cowden syndrome and Bannayan–Riley–Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers , 2007, Journal of Medical Genetics.

[7]  Andreas Zankl,et al.  ABase—A tool for the rapid assessment of anthropometric measurements on handheld computers , 2003, American journal of medical genetics. Part A.

[8]  L. Hudgins,et al.  The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome , 2001, Journal of Medical Genetics.

[9]  K. McBride,et al.  Genetic testing in autism: how much is enough? , 2007, Genetics in Medicine.

[10]  Lester R Curtin,et al.  Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. , 2002, Pediatrics.

[11]  J. Dixon,et al.  PTEN: a tumour suppressor that functions as a phospholipid phosphatase. , 1999, Trends in cell biology.

[12]  L. Farkas.  Anthropometry of the head and face , 1994 .

[13]  P. George,et al.  Identification of a novel PTEN mutation (L139X) in a patient with Cowden disease and Sjögren's syndrome. , 1998, Molecular pathology : MP.

[14]  J. Ivanovich,et al.  Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. , 2003, American journal of human genetics.

[15]  Warren C. Lathe,et al.  Prediction of deleterious human alleles. , 2001, Human molecular genetics.

[16]  J. Mulliken,et al.  The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management , 2007, Journal of Medical Genetics.

[17]  L. Hoefsloot,et al.  PTEN mutation in a family with Cowden syndrome and autism. , 2001, American journal of medical genetics.

[18]  R. Houlston,et al.  Overgrowth syndromes: is dysfunctional PI3-kinase signalling a unifying mechanism? , 2003, European Journal of Human Genetics.

[19]  B. Leventhal,et al.  The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism , 2000, Journal of autism and developmental disorders.

[20]  G S Taylor,et al.  PTEN and myotubularin: novel phosphoinositide phosphatases. , 2001, Annual review of biochemistry.

[21]  C. Eng,et al.  Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. , 1998, American journal of medical genetics.

[22]  C. Rice,et al.  Prevalence of autism in a US metropolitan area. , 2003, JAMA.

[23]  Charis Eng,et al.  PTEN: One Gene, Many Syndromes , 2003, Human mutation.

[24]  C Eng,et al.  Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations , 2005, Journal of Medical Genetics.